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Host control of Coxiella burnetii infections is believed to be mediated primarily by activated monocytes/
macrophages. The activation of macrophages by cytokines leads to the production of reactive oxygen interme-
diates (ROI) and reactive nitrogen intermediates (RNI) that have potent antimicrobial activities. The contri-
butions of ROI and RNI to the inhibition of C. burnetii replication were examined in vitro by the use of murine
macrophage-like cell lines and primary mouse macrophages. A gamma interferon (IFN-) treatment of
infected cell lines and primary macrophages resulted in an increased production of nitric oxide (NO) and
hydrogen peroxide (H2O2) and a significant inhibition of C. burnetii replication. The inhibition of replication
was reversed in the murine cell line J774.16 upon the addition of either the inducible nitric oxide synthase
(iNOS) inhibitor NG-monomethyl-L-arginine (NGMMLA) or the H2O2 scavenger catalase. IFN--treated pri-
mary macrophages from iNOS/ and p47phox/mice significantly inhibited replication but were less efficient
at controlling infection than IFN--treated wild-type macrophages. To investigate the contributions of ROI and
RNI to resistance to infection, we performed in vivo studies, using C57BL/6 wild-type mice and knockout mice
lacking iNOS or p47phox. Both iNOS/ and p47phox/ mice were attenuated in the ability to control C.
burnetii infection compared to wild-type mice. Together, these results strongly support a role for both RNI and
ROI in the host control of C. burnetii infection.
Coxiella burnetii, the etiologic agent of Q fever, is an obligate
intracellular bacterium. Q fever is a zoonosis that is found
worldwide, with a broad host range that includes wild and
domestic mammals, birds, arthropods, and humans (9). For
humans, the primary route of infection is through the inhala-
tion of contaminated aerosols associated with domestic rumi-
nants (40). Following inhalation, the organism is taken up
primarily by resting alveolar macrophages, replicates to high
numbers, and disseminates to a variety of tissues upon host cell
rupture. Q fever can manifest as an acute illness that resembles
influenza or as a chronic illness that is most often characterized
by endocarditis. Clinically, acute Q fever is generally a self-
limiting febrile illness that can be readily treated with tetracy-
clines to accelerate recovery (49). Conversely, chronic Q fever
is refractory to antibiotics, with significant mortality rates even
when patients receive the most effective treatment currently
available, which is doxycycline plus chloroquine for at least 18
months (51).
C. burnetii has the unique ability among bacteria to replicate
within an acidified vacuole of a resting host cell despite the
presence of toxic host factors such as acid hydrolases and
defensins (4). Although both infection with viable C. burnetii
and vaccination with killed whole-cell C. burnetii lead to the
development of humoral and cell-mediated immune responses,
the host defense appears to be dependent on the enhanced
microbicidal mechanisms of macrophages that are activated by
specifically sensitized T cells (7, 33, 36). Previous studies have
demonstrated that the activation of guinea pig monocytes,
THP-1 monocytes, L929 murine fibroblasts, and primary
mouse macrophages by gamma interferon (IFN-) results in
the inhibition of C. burnetii replication (20, 31, 32, 54, 57).
However, only a few studies have been done to determine the
mechanisms used by either professional or nonprofessional
phagocytes to control C. burnetii replication. Dellecasagrande
et al. reported that infected THP-1 monocytes stimulated with
IFN- were able to inhibit phase I C. burnetii replication and
suggested that a tumor necrosis factor alpha-driven apoptotic
mechanism may be involved (20). Recently, Howe et al. dem-
onstrated that nitric oxide (NO) reversibly inhibits the repli-
cation of avirulent phase II C. burnetii in IFN--treated L929
murine fibroblasts (32). Zamboni and Rabinovitch reported
that phase II C. burnetii induced NO in primary mouse mac-
rophages and that this NO was partially responsible for reduc-
ing the numbers of C. burnetii organisms in these cells. They
also demonstrated that IFN--treated primary macrophages
from inducible nitric oxide synthase-negative (iNOS/) mice
controlled phase II C. burnetii infections, which suggests that
NO-independent mechanisms were also involved (57).
IFN--activated macrophages are capable of generating re-
active oxygen intermediates (ROI) and reactive nitrogen inter-
mediates (RNI) that enhance the ability of these cells to con-
trol the growth of intracellular organisms. IFN- stimulation
results in the activation of NADPH oxidase and iNOS.
NADPH oxidase reduces oxygen to a superoxide anion (O2
),
which can then enter the phagosome and be changed to hy-
drogen peroxide (H2O2) by a dismutase (17). iNOS synthesizes
NO from L-arginine and oxygen. Reactive oxygen and nitrogen
intermediates can inactivate [4Fe-4S] cluster-containing en-
zymes, damage DNA, and oxidize cellular membranes and
enzymes (21, 27, 56). The antimicrobial activities of these in-
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termediates have been demonstrated in vitro as well as in vivo.
Mycobacterium tuberculosis, Leishmania donovani, and Rickett-
sia conorii have all been shown to be susceptible to H2O2
killing in vitro (22, 34, 43). Mice lacking gp91phox, which results
in an NADPH oxidase deficiency, have an increased suscepti-
bility to M. tuberculosis and L. donovani infections (2, 44). Mice
lacking a functional iNOS were more susceptible to a challenge
with virulent M. tuberculosis and died earlier after the chal-
lenge than did wild-type mice (38, 52). Also, the inhibition of
iNOS resulted in a more rapid progression of chronic tuber-
culosis in wild-type mice (38). While prior studies have inves-
tigated the role of NO in controlling phase II C. burnetii in-
fections in vitro, the goal of this study was to evaluate the roles
that RNI and ROI play in the inhibition of virulent phase I C.
burnetii infections in vitro and in vivo. To accomplish this goal,
we conducted experiments in vitro, using J774 macrophage-
like cell lines and primary macrophages from iNOS and
p47phox knockout (KO) mice, and in vivo challenge experi-
ments, using iNOS and p47phox KO mice.
MATERIALS AND METHODS
Macrophage killing experiments. (i) Reagents. Murine recombinant IFN-,
hypoxanthine, and xanthine oxidase were purchased from Calbiochem (La Jolla,
Calif.). Griess reagent, NG-monomethyl-L-arginine, catalase, horseradish perox-
idase (HRPO), phenol red, and Hanks’ balanced salt solution were purchased
from Sigma (St. Louis, Mo.). Experiments with macrophages were conducted in
a biosafety level III laboratory.
(ii) J774 mouse macrophage experiments. Two murine phagocytic cell lines—
J774.16, a strong oxidative burst-competent cell line (18), and J774D.9, which
fails to generate an oxidative burst after phorbol myristate acetate stimulation
(24)—were assessed for the ability to control C. burnetii replication with and
without activation by IFN-. Hypoxanthine/xanthine oxidase (HX/XO) (an ROI
donor) (12), catalase, and NG-monomethyl-L-arginine (NMMLA) (a nitric oxide
synthase inhibitor) (30) were included to determine the effects of ROI and RNI
on bacterial replication. Briefly, cells were plated at 105/ml in 24- or 96-well tissue
culture plates and then allowed to adhere for 4 h. Macrophages were infected
with purified C. burnetii (Nine Mile, phase I, RSA 493) at a multiplicity of
infection of 35:1, incubated overnight at 37°C in 5% CO2, and then washed three
times with warm medium to remove any uninternalized bacteria. Infected cells
were then left untreated or were treated with IFN- (100 U/ml) alone or in
combination with 1 mM NMMLA, 100 M catalase, or 250 M/30 M HX/XO
on days 1, 2, 3, 4, and 5 postinoculation. The ability of C. burnetii to replicate in
these cells was assessed at 2, 4, and 6 days postinfection. The generation of NO
and H2O2 was detected spectrophotometrically by the use of Griess reagent (25)
and by the horseradish peroxidase-dependent oxidation of phenol red (47),
respectively, in 96-well plates. The replication of C. burnetii was monitored by
real-time PCR as previously described (14), using cells harvested from 24-well
plates. Cell viability was determined by trypan blue exclusion.
(iii) Primary macrophage experiments. Peritoneal macrophages were har-
vested from C57BL/6, p47phox/ (C57BL/6), and iNOS/ (C57BL/6) mice
(Taconi Farms Inc., Germantown, N.Y.) to obtain macrophages that were com-
petent in both respiratory burst and nitric oxide production and macrophages
that lacked a functional respiratory burst or nitric oxide production. Resident
peritoneal macrophages (PM) were collected by washing the peritoneal cavity
of CO2-euthanized mice with 6 ml of cold RPMI containing 10% fetal bovine
serum. The cells were plated in 24- and 96-well tissue culture plates at 2  105
cells/well in cold RPMI containing 10% fetal bovine serum, 1% L-glutamine, 5%
L-cell medium, and 1% penicillin-streptomycin and were allowed to adhere for
24 h at 37°C in 5% CO2.
Primary macrophages were infected with purified C. burnetii (Nine Mile, phase
I, RSA 493) at a multiplicity of infection of 35:1, incubated overnight at 37°C in
5% CO2, and then washed three times with warm medium to remove any
uninternalized bacteria. Infected cells were then treated with IFN- (100 U/ml)
or were left untreated.
C. burnetii infection in mice. C57BL/6, p47phox/ (C57BL/6), and iNOS/
(C57BL/6) mice (Taconi Farms Inc.) were challenged intraperitoneally with 104
or 107 phase I C. burnetii cells suspended in phosphate-buffered saline. The mice
were observed daily for morbidity and mortality for 28 days postchallenge. Body
weights were measured on days 14 and 28 postchallenge. On days 14 and 28
postchallenge, the mice were euthanized by the use of CO2, and their spleens
were collected and evaluated for splenomegaly. Spleen, lung, liver, and heart
valve samples were also collected for histopathology and immunocytochemistry.
Experiments were conducted in a biosafety level III laboratory.
Histopathology and immunocytochemistry. Lungs, livers, spleens, and heart
valves were collected at 14 and 28 days postinfection, fixed for 48 h in 10%
buffered formalin, and then stored in 70% ethanol until sectioning. Sectioned
tissues were embedded in paraffin, cut to a 5-m thickness, affixed to slides, and
stained with hematoxylin and eosin. The distribution of C. burnetii cells was
determined by immunocytochemistry, using a rabbit anti-C. burnetii Nine Mile
phase I antiserum, goat anti-rabbit immunoglobulins, and an avidin-biotin com-
plex (ABC; Vector Laboratories, Burlingame, Calif.).
Measurement of nitric oxide. Cell culture supernatants were collected, and the
accumulation of NO2, a stable end product of NO formation, was measured as
an indicator of NO production. One hundred microliters of each supernatant
plus 100 l of Griess reagent was incubated at room temperature for 15 min, and
then the absorbance was measured at 570 nm. The concentration of NO in the
samples was calculated from a standard curve of sodium nitrite (25).
Measurement of hydrogen peroxide. Supernatants were removed from the
wells of the plates, and the macrophages were covered with 100 l of a phenol
red-HRPO solution containing stimulants per well. One vertical row served as a
blank and contained 100 l of the phenol red-HRPO solution per well plus 10 l
of 1 N NaOH. The plates were incubated for 1 h at 37°C in 5% CO2. The reaction
was interrupted by the addition of 10 l of 1 N NaOH per well. After a 3-min
interval, the absorbance was read at 630 nm. The concentration of H2O2 was
calculated from a standard curve of H2O2 (47).
Estimation of bacterial doubling times. Doubling times for C. burnetii were
calculated by using the formula G t/[3.3 log(b/B)], where G is the generation
time, t is the time interval, in hours or minutes, b is the number of bacteria at the
end of the interval (144-h time point), and B is the number of bacteria at the
beginning of the time interval (96-h time point) (http://textbookofbacteriology
.net/growth.html).
Statistics. Significant differences between means were determined by the Stu-
dent t test by use of the Microsoft Excel statistics analysis pack. Differences were
considered statistically significant when P values were 0.05 (indicated by aster-
isks in the figures). Significant differences between the replication rates were
determined by performing a two-tailed Student t test on the average growth rates
in each cell type calculated between the 96- and 144-h time points. Differences
were considered statistically significant when P values were 0.05.
RESULTS
C. burnetii replication rates. Bacterial loads were deter-
mined by real-time PCR on days 2, 4, and 6 postinfection in
J774.16 and J774D.9 cells (Fig. 1A) and in PM (Fig. 1B). The
estimated doubling times for bacteria were 45 h in J774.16
cells, 20 h in J774D.9 cells, 26 h in wild-type PM, 19 h in
p47phox/ PM, and 17 h in iNOS/ PM. Although there
does appear to be some differential uptake of C. burnetii by the
various cell types, particularly as shown in Fig. 1B, the ability of
a cell to take up bacteria is not directly related to the bacterial
growth rate once the bacteria have been phagocytized. There-
fore, calculating the doubling times of bacteria in cells dem-
onstrating differential uptake rates is justified. The doubling
times of C. burnetii were significantly shorter (P 0.05) in cells
that were defective for NADPH oxidase or iNOS. These re-
sults suggest that wild-type macrophages provide a more
growth-restrictive environment than NADPH oxidase- or
iNOS-defective macrophages and that the expression of oxy-
gen and nitrogen radicals contributes to this growth suppres-
sion. Bacterial doubling times in all cell types were calculated
for the interval from 96 to 144 h in an effort to estimate
bacterial growth rates during the period of exponential growth.
Effects of nitric oxide and H2O2 on C. burnetii replication in
J774 cell lines. Nitric oxide production by J774 cell lines and
primary macrophages was determined by measuring nitrite, a
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stable end product of nitric oxide production. The results show
that C. burnetii infection alone was not sufficient to stimulate
J774.16 or J774D.9 cells to produce significant levels of nitrite
(Fig. 2A and B). IFN- treatment of infected macrophages
resulted in a significant (P  0.01) increase in nitrite produc-
tion in both macrophage cell lines at 96 and 144 h postinfec-
tion. The nitric oxide inhibitor NMMLA was able to suppress
nitrite production by 90% in J774.16 cells and by 74% in
J774D.9 cells. IFN- treatment of infected macrophages also
resulted in a significant (P  0.05) production of H2O2 by
J774.16 cells, but not J774D.9 cells (Fig. 2C and D). The H2O2
scavenger catalase reduced H2O2 levels by 85% in J774.16
cells. IFN--activated J774.16 cells significantly (P  0.05)
inhibited the replication of C. burnetii by 144 h postinfection
(Fig. 3A). The replication rate was restored to nearly the level
in untreated cells in the presence of the iNOS inhibitor
NMMLA, suggesting that a nitric oxide-dependent mechanism
is involved in controlling C. burnetii infections in macrophages.
Bacterial replication was restored in J774.16 cells by the addi-
tion of catalase. Furthermore, IFN--activated J774D.9 mac-
rophages, which lack a functional respiratory burst, were un-
able to significantly inhibit C. burnetii replication unless an
exogenous source of H2O2 provided by HX/XO was added
(Fig. 3B). Together, these results suggest that an oxygen-rad-
ical-dependent mechanism is also involved in controlling C.
burnetii infections in macrophages.
The viabilities of untreated and treated J774.16 and J774
cells were similar and remained above 86% throughout the
experiment, as determined by trypan blue exclusion, indicating
that the inhibition of C. burnetii replication was not due to host
cell death.
Effects of nitric oxide and H2O2 on C. burnetii replication in
primary mouse macrophages. Since low levels of NO and
H2O2 were still detectable in the presence of iNOS or NADPH
oxidase inhibitors, we wanted to further define and clarify the
contributions of NO and H2O2 to the inhibition of C. burnetii
replication in vitro. To this end, we performed experiments
using primary peritoneal macrophages from iNOS/,
p47phox/, and wild-type C57BL/6 mice. The cells were in-
fected for 24 h and then left untreated or treated with 100 U of
IFN-/ml for 5 days. On day 6 postinfection, the bacterial loads
in the macrophages, as well as NO and H2O2 levels, were
determined. As predicted, IFN- treatment of the macro-
phages resulted in an increased production of NO in wild-type
and p47phox/ macrophages but not in iNOS/ macrophages
(Fig. 4A) and in an increased production of H2O2 in wild-type
and iNOS/ macrophages but not in p47phox/ macrophages
(Fig. 4B). IFN--treated wild-type, p47phox/, and iNOS/
PM all significantly inhibited C. burnetii replication compared
to untreated PM (Fig. 4C). However, when compared to
wild-type PM, p47phox/ and iNOS/ PM were less ef-
fective at controlling replication, which supports a role for both
NO and H2O2 in controlling C. burnetii infections (Fig. 4C).
Peritoneal macrophages lacking NADPH oxidase were not as
effective as iNOS/ PM at controlling replication, suggest-
ing that oxygen radicals play a larger role than NO in inhibiting
C. burnetii growth in these cells.
Contributions of RNI and ROI in vivo. (i) Clinical signs and
gross pathology in mice. To investigate whether oxygen or
nitrogen radicals are required for resistance to C. burnetii in-
fections in vivo, we infected wild-type, iNOS/, and
p47phox/ mice intraperitoneally with either 104 or 107 C.
burnetii cells and evaluated them for morbidity, pathology, and
bacterial distribution at 14 and 28 days postinfection (dpi). At
14 dpi, the p47phox/ mice who were infected at the 107 dose,
and to a lesser extent those who were infected at the 104 dose,
failed to thrive and showed clinical signs of illness, including a
hunched posture, a ruffled hair coat, and mild lethargy. No
clinical signs were observed for wild-type and iNOS/ mice
who were infected with either dose of C. burnetii, except for
distended abdomens due to splenomegaly. Pinpoint white foci
were seen in the livers of three of four infected (107 dose)
p47phox/ and one of four infected (107 dose) iNOS/ mice,
suggesting a hematogenous dissemination of the organism. No
foci were seen in the livers of the unchallenged controls or
wild-type mice at either infectious dose. At 14 dpi, significant
increases in spleen mass were observed for all mice who were
challenged with 104 and 107 cells compared to unchallenged
controls (Fig. 5A). At the 107 dose, spleens from iNOS/
mice were significantly larger than those from wild-type mice,
while p47phox/ spleens were noticeably smaller. At 28 dpi,
FIG. 1. Estimated generation times for C. burnetii in J774 cells and
primary murine macrophages. Generation times were calculated by the
formula G t/[3.3 log(b/B)], where G is the generation time, t is the
time interval, in hours, b is the number of bacteria at the end of the
time interval, and B is the number of bacteria at the beginning of the
time interval. (A) Replication rates in J774.16 cells. J774.16, 45 h;
J774D.9, 20 h. (B) Replication rates in peritoneal macrophages. Wild-
type PM, 26 h; p47phox/ PM, 19 h; iNOS/ PM, 17 h. C.
burnetii replication rates in cells lacking either iNOS or NADPH oxi-
dase were significantly (P  0.05) faster than replication rates in
wild-type cells.
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the p47phox/ mice who were challenged with either 104 or
107 C. burnetii organisms had begun to resolve the clinical signs
of disease, except for the distended abdomens. Infected wild-
type and iNOS/ mice remained clinically normal aside from
having distended abdomens. Marked splenomegaly was still
evident in all infected mice, with a higher degree of enlarge-
ment in mice infected with 107 cells (Fig. 5B). Spleens from
p47phox/ mice were significantly larger than those from wild-
type or iNOS/ mice at both infectious doses. Spleens from
wild-type and iNOS/ mice were significantly smaller at 28
dpi than at 14 dpi for mice infected with the 104 dose.
(ii) Histopathology. At 14 dpi, the lungs of all mice displayed
various degrees of perivascular histiocytic (granulomatous) in-
terstitial pneumonia, with a decrease in the overall airspace.
Bronchiolar involvement was occasionally seen, with increased
peribronchiolar mononuclear cells and some desquamation of
bronchiolar epithelial cells. The severity of the lung changes
was greater for mice infected with 107 organisms than for mice
infected with 104 organisms and was greatest for p47phox/
mice (Table 1). p47phox/ mice, even those infected at the
lower dose, exhibited moderate to severe perivascular histio-
cytic hepatitis. Lesser changes were noted for iNOS/ and
wild-type mice (Table 1). Marked extramedullary hematopoi-
esis with myeloid, erythroid, and megakaryocytic hyperplasia, a
normal finding in mice, was noted in the livers and spleens of
all infected mice compared to uninfected controls. All infected
mice had histiocytic splenitis, and again, the p47phox/ mice
displayed the largest degree of change, including rare necrotic
foci in the mice infected with the 107 dose. The spleens of
wild-type mice, and to a slightly lesser extent those of iNOS/
mice, had diffuse lymphoid hyperplasia. Mild myocarditis and
valvular endocarditis were noted for all infected mice. No
pathological lesions were noted for control animals.
At 28 dpi, the interstitial pneumonia was resolving in all
infected mice, and only a mild decrease in the airspace re-
mained. However, moderate perivascular histiocytic pneumo-
nia was still present in the p47phox/ mice (Table 1). The
livers continued to have granulomatous lesions, with minimal
focal necrosis now present in infected animals (107 dose).
Splenic plasmacytosis was noted for infected wild-type mice,
indicating a resolution of the histiocytic splenitis noted at 14
dpi. The spleens of iNOS/ mice contained more histiocytes
FIG. 2. Nitrite and hydrogen peroxide levels in J774.16 and
J774D.9 cells. The cells were infected for 24 h with virulent phase I C.
burnetii and then were treated with 100 U of murine rIFN-/ml in the
presence or absence of the iNOS inhibitor NMMLA (1 mM) or the
hydrogen peroxide scavenger catalase (100 M). The stimulation of
iNOS was indirectly determined by measuring nitrite, which is a stable
end product of nitric oxide production. Hydrogen peroxide levels were
determined by measuring the horseradish peroxidase-dependent oxi-
dation of phenol red. (A) Nitrite levels in J774.16 cells. (B) Nitrite
levels in J774D.9 cells. (C) Hydrogen peroxide levels in J774.16 cells.
(D) Hydrogen peroxide levels in J774D.9 cells. (A and B) Stippled
bars, no treatment; diagonally striped bars, treatment with 100 U of
IFN-/ml; vertically striped bars, treatment with 100 U of IFN-/ml
and 1 mM NMMLA. (C) Stippled bars, no treatment; diagonally
striped bars, treatment with 100 U of IFN-/ml; vertically striped bars,
treatment with 100 U of IFN-/ml and 100 M catalase. (D) Stippled
bars, no treatment; diagonally striped bars, treatment with 100 U of
IFN-/ml. The results are expressed as means and standard errors for
three replicates from two independent experiments. Asterisks indicate
significant differences between treated and untreated samples within
the same time points.
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and fewer plasma cells than those of wild-type mice.
p47phox/ mice continued to have severe perivascular histio-
cytic splenitis with marked extramedullary hematopoiesis, min-
imal focal necrosis, and a lack of follicle organization. Mild
myocarditis and valvular endocarditis were noted for all in-
fected mice. Venous microthrombi were present in multiple
organs, including lungs, livers, and spleens.
(iii) Immunocytochemistry. C. burnetii cells were immuno-
localized in lung, liver, spleen, and heart valve samples from
wild-type, iNOS/, and p47phox/ mice at 14 and 28 days
postinfection. At 14 days postinfection, bacteria were detected
in all of the tissues from the iNOS/ and p47phox/ mice at
both challenge doses (Table 2). In general, more organisms
were detected in a larger number of tissues in mice receiving
the higher challenge dose. No bacteria were detected in the
lungs of wild-type mice at either challenge dose. iNOS/ and
p47phox/ mice were more heavily colonized with C. burnetii
than wild-type mice, and the bacteria were more widely dis-
seminated in the tissues.
In general, at 28 dpi the bacterial burdens had decreased in
all infected animals at both challenge doses compared to those
at 14 dpi, with the exception of the heart valves of iNOS/
and p47phox/ mice. The heart valves from iNOS/ and
FIG. 3. Effects of IFN- treatment on C. burnetii growth in J774.16
and J774D.9 cells. At 48, 96, and 144 h postinfection, infected cells
were harvested, and the numbers of C. burnetii organisms, represented
as numbers of Coxiella genomes, were determined by real-time PCR.
(A) J774.16 cells were infected for 24 h with virulent phase I C. burnetii
and then were treated with 100 U of murine rIFN-/ml in the presence
or absence of the iNOS inhibitor NMMLA (1 mM) or the hydrogen
peroxide scavenger catalase (100 M). (B) J774D.9 cells were infected
for 24 h with virulent phase I C. burnetii and then were treated with 100
U of murine rIFN-/ml in the presence or absence of the iNOS inhib-
itor NMMLA (1 mM) or the ROI donor HX/XO (250 M/30 M).
The results are expressed as means and standard errors for three
replicates from two independent experiments. Asterisks indicate sig-
nificant differences between treated and untreated samples within the
same time points.
FIG. 4. Growth of virulent phase I C. burnetii in primary murine
peritoneal macrophages. Macrophages were infected for 24 h with
virulent phase I bacteria and then treated for 5 days with or without
100 U of IFN-/ml. Nitrite and hydrogen peroxide levels were deter-
mined for primary murine peritoneal and bone marrow-derived mac-
rophages. Levels of nitrite (A) and hydrogen peroxide (B) were mea-
sured at 144 h postinfection as described for the J774 cell lines.
Stippled bars, no treatment; diagonally striped bars, treatment with
100 U of IFN-/ml. (C) At 144 h postinfection, peritoneal macro-
phages were harvested, and the numbers of C. burnetii were deter-
mined by real-time PCR. Stippled bars, wild type; diagonally striped
bars, p47phox/; vertically striped bars, iNOS/. The results are ex-
pressed as means and standard errors for three replicates. Asterisks
indicate significant differences between treated and untreated samples.
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p47phox/ mice at both challenge doses contained larger and
more numerous foci of infection at 28 dpi than at 14 dpi (Table
2). The distribution of bacteria continued to be more wide-
spread in iNOS/ and p47phox/ mice than in wild-type mice
in all tissues in which C. burnetii was still detected. Figure 6
illustrates the degree of bacterial deposition in the heart valves
of mice who were challenged with 107 C. burnetii cells at 28
days postinfection.
DISCUSSION
C. burnetii is an obligate intracellular pathogen that survives
by multiplying in acidified vacuoles of monocytes/macrophages
and whose virulence depends on the expression of lipopolysac-
charide (LPS). Virulent, phase I bacteria express a complete,
or smooth-type, LPS and can be recovered from infected ani-
mals, whereas avirulent, phase II bacteria express a truncated,
or rough-type, LPS and cannot be recovered from infected
animals (29). However, phase I and phase II bacteria are able
to replicate in numerous cell types in vitro (4, 13, 20, 31, 32, 54,
57), and several studies have demonstrated the ability of cyto-
kine-activated cells to inhibit phase I and phase II C. burnetii
replication (20, 32, 54, 57). Recent reports have demonstrated
roles for NO in phase II inhibition in L929 murine fibroblasts
(32, 57) and a possible role for apoptosis in the elimination of
phase I bacteria from human monocytes (20). However, the
FIG. 5. Splenomegaly in C57BL/6, iNOS/, and p47phox/ mice.
Mice were challenged intraperitoneally with 104 or 107 C. burnetii cells.
At 14 (A) and 28 (B) dpi, spleens were collected and evaluated for
splenomegaly. Stippled bars, wild type; diagonally striped bars,
iNOS/; vertically striped bars, p47phox/. The results are expressed
as means and standard errors for four mice. Asterisks indicate signif-
icant differences between wild-type and knockout mice.
TABLE 1. Severity of histopathologic changes in selected tissues of
mice infected with C. burnetii
Tissue or
mouse strain
Histopathology scorea with indicated dose
of C. burnetii
104 107
14 dpi 28 dpi 14 dpi 28 dpi
Lung
Wild type 2 0 3 1
iNOS KO 3 1 4 1
phox KO 4 2 5 3
Liver
Wild type 3 2 4 3
iNOS KO 2 1 4 3
phox KO 2 3 5 4
Spleen
Wild type 3 2 5 4
iNOS KO 3 3 5 4
phox KO 5 5 5 5
a Severity was based on the amount of architectural change, cellular infiltra-
tion, and the presence or absence of necrosis: 0, none; 1, mild; 2, mild to
moderate; 3, moderate; 4, moderate to severe; 5, severe. One section from three
mice per group was evaluated. The evaluation of tissue sections was done in a
blinded fashion.
TABLE 2. Immunolocalization of C. burnetii in mice
Tissue or time
after infection Mouse strain
Immunolocalization of
C. burnetii at indicated dosea
104 107
14 dpi
Lung Wild type  
iNOS KO  
phox KO  
Liver Wild type  
iNOS KO  
phox KO  
Spleen Wild type  
iNOS KO  
phox KO  
Heart valve Wild type  
iNOS KO  
phox KO  
28 dpi
Lung Wild type  
iNOS KO  
phox KO  
Liver Wild type  
iNOS KO  
phox KO  
Spleen Wild type  
iNOS KO  
phox KO  
Heart valve Wild type  
iNOS KO  
phox KO  
a , no organisms present in the tissue section; , the presence of the organ-
ism is rare and focal; , few organisms are present, and they are multifocal;
, many organisms are present, and they are diffuse; , abundance of
organisms are present, and they are diffuse. One section from four mice per
group was evaluated. The evaluation of tissue sections was done in a blinded
fashion.
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potential contributions of ROI in controlling C. burnetii infec-
tions have not been fully investigated. Zamboni et al. reported
that the addition of catalase or superoxide dismutase to phase
II-infected bone marrow-derived macrophages had no effect
on the relative bacterial loads in untreated or IFN--treated
bone marrow-derived macrophages. This report alluded to a
finding that C. burnetii expresses superoxide dismutase and
catalase activities (3) and suggested that these enzyme systems
can fully protect C. burnetii from ROI (57). However, other
pathogens such as Salmonella enterica serovar Typhimurium
and Brucella abortus, which also express superoxide dismutase
and catalase enzymes, are susceptible to ROI killing (35, 55),
indicating that possessing and expressing ROI defense mech-
anisms does not necessarily equate protection from the high
level of ROI induced by IFN- activation. Dellecasagrande et
al. have shown that THP-1 monocytes, monocytes from healthy
humans, and monocytes from patients suffering from chronic
granulomatous disease controlled phase I C. burnetii infections
despite undetectable levels of RNI or ROI (20). The differ-
ences in the capacities of monocytes and macrophages to gen-
erate ROI and RNI have been well documented (1, 16); thus,
the apoptotic mechanism of controlling C. burnetii replication
may be a unique but effective alternative for cells such as
monocytes that lack the traditional microbicidal capacities of
macrophages. Howe et al. proposed that since the phagocytosis
of C. burnetii does not stimulate a respiratory burst, as defined
by the detection of O2
 (5), C. burnetii would not be exposed to
toxic peroxynitrite (ONOO), which is formed through the
interaction of superoxide with nitric oxide. However, our re-
sults demonstrate that the respiratory burst is activated upon
the stimulation of infected macrophages with IFN-, as de-
fined by the detection of H2O2. We also detected superoxide
(O2
) produced by IFN- activation (data not shown). Re-
cently, Korshunov et al. demonstrated that under acidic con-
ditions, protonated superoxide penetrated lipid membranes at
rates similar to water and reported that when Escherichia coli
CuZnSOD mutants were exposed to superoxide at a low pH,
cytosolic fumerase B was damaged (37). Protonated superox-
ide can also react with itself to form H2O2 (42). Therefore, due
to the acidic nature of the vacuole in which C. burnetii resides,
we propose that C. burnetii is exposed to a variety of toxic
radicals, including O2
, NO, H2O2, and ONOO
. In this re-
port, we demonstrated that both RNI and ROI contribute to
controlling phase I C. burnetii infections in vivo as well as in
vitro.
The doubling times for C. burnetii were determined in
cloned and primary macrophages. Bacterial loads were deter-
mined at 48, 96, and 144 h postinfection. Twenty-four-hour
time points were not taken because the overall goal of the
project was to investigate the effects of iNOS and NADPH
oxidase on bacterial replication. Thus, the 48-h time point
represents the first time point (24 h after treatments) for which
comparisons could be made regarding the effects of iNOS and
NADPH oxidase on C. burnetii growth in untreated and
treated cells. The doubling times were calculated for untreated
samples. Doubling times were determined by using the 96- and
144-h time points as time zero and the end time, respectively,
in an effort to calculate doubling times only during the period
of exponential growth. The use of these time points also di-
minished any effects of initial bacterial uptake on the calcu-
FIG. 6. Immunolocalization of C. burnetii in cardiac valve sections
from mice challenged with 107 C. burnetii organisms at 28 days postin-
fection. C. burnetii was detected by the ABC method (Vector Labora-
tories). (A) Valve section from wild-type mouse; (B) valve section from
iNOS/ mouse; (C) valve section from p47phox/ mouse. The red to
rust-colored deposits represent the presence of C. burnetii (arrows
denote examples). At, atrial side; V, ventricular side. Magnification,
40.
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lated growth rates. The replication rates of C. burnetii were
approximately two times faster in NADPH oxidase- or iNOS-
defective macrophages, suggesting that RNI and ROI may be
partially responsible for the slower growth rates in immuno-
competent cells. These findings are similar to those of a pre-
vious report that demonstrated that phase II bacterial loads
were larger in unstimulated primary macrophages treated with
iNOS-inhibiting agents than in unstimulated, untreated pri-
mary macrophages (57). One possibility for the extended dou-
bling times observed in NADPH oxidase and iNOS competent
cells is that C. burnetii may devote more energy to up-regulat-
ing genes that are necessary to detoxify low levels of reactive
nitrogen and oxygen intermediates that may be present in
resting macrophages. For example, stationary-phase infectious
Legionella pneumophila has been demonstrated to express sev-
eral virulence traits, including catalase and superoxide dis-
mutase, that are thought to be important for L. pneumophila to
establish an infection (10, 11, 53).
To determine the effects of iNOS and NADPH oxidase on
phase I C. burnetii infections in vitro, we monitored bacterial
replication in IFN--activated J774 cell lines that differed in
the ability to produce ROI. IFN--activated J774.16 macro-
phages significantly inhibited bacterial replication, and this
inhibition was reversed by the addition of either the iNOS
inhibitor NMMLA or the H2O2 scavenger catalase, suggesting
that RNI and ROI both contribute to controlling C. burnetii
infections. Interestingly, the inhibition of iNOS did not fully
rescue the growth defect of C. burnetii in IFN--treated mac-
rophages, whereas the inhibition of H2O2 did appear to fully
rescue and possibly promote bacterial replication, suggesting
that ROI, and H2O2 in particular, may play a larger role than
RNI in controlling infections in these cells. Similar effects were
seen by Feng and Walker in cytokine-treated Rickettsia conorii-
infected human umbilical vein endothelial cells (22). The ad-
dition of NMMLA to cytokine- and chemokine-treated in-
fected human umbilical vein endothelial cells resulted in an
approximately 85% recovery of bacterial growth, while the
addition of catalase led to an approximately 160% recovery.
This apparent augmentation of replication may be a result of
relieving the stress of endogenous ROI as well as exogenous
ROI. IFN--activated J774D.9 macrophages, which lack a
functional NADPH oxidase, only significantly inhibited bacte-
rial replication when an exogenous source of H2O2 was added,
which also indicates the importance of ROI in controlling
infections. The finding that the inhibition of either iNOS or
NADPH oxidase resulted in a rescue of growth suggests that
the control of C. burnetii is in part due to the synergistic effects
of RNI and ROI.
In an effort to substantiate the in vitro findings from the
cloned cell lines, we employed primary macrophages that dif-
fered in the ability to produce ROI and RNI, which allowed us
to avoid the use of inhibitors or donors that may have had
incomplete or nonspecific effects. Although IFN--activated
iNOS/ and p47phox/ macrophages did not produce signif-
icant amounts of NO or H2O2, respectively, they did inhibit
bacterial replication significantly more than untreated controls.
These data suggest that in addition to RNI- and ROI-depen-
dent mechanisms, the activation of macrophages results in
bacteriostatic mechanisms that are independent of iNOS and
NADPH oxidase. Several investigators have demonstrated that
IFN- activation results in iron limitation and tryptophan star-
vation, which serve to inhibit the growth of other intracellular
pathogens (23, 26, 39, 46). Interestingly, activated iNOS/
peritoneal macrophages were only slightly less effective while
activated p47phox/ peritoneal macrophages were signifi-
cantly less effective at controlling infections than activated
wild-type peritoneal macrophages, suggesting that ROI may
play a more significant role in controlling C. burnetii infections
than RNI in these cells.
This hypothesis was further supported by the finding that
mice lacking iNOS were less effective at controlling C. burnetii
infections than wild-type mice and that NADPH oxidase-defi-
cient mice were even less effective than iNOS/ mice. Al-
though a dose-dependent splenomegaly was apparent in all
infected mice, the phenotypes of the iNOS/ and p47phox/
mice were markedly different from that of wild-type mice. The
iNOS/ mice appeared to have an initial period of increased
susceptibility followed by a period of recovery, as indicated by
the presence of liver foci and significant splenomegaly at 14 dpi
and by no liver foci and splenomegaly similar to that of wild-
type mice at 28 dpi. The p47phox/ mice appeared to have a
more severe phenotype than the iNOS/ mice. At 14 dpi,
more of these mice possessed liver foci and developed clinical
signs of illness, and by 28 dpi these mice demonstrated signif-
icantly more splenomegaly than wild-type mice. These data
support the general hypothesis that ROI play a more signifi-
cant role in protection than RNI in the infection of mice.
The findings that both iNOS/ and p47phox/ mice were
more susceptible to infection than wild-type mice and that
either iNOS or H2O2 inhibitors were able to rescue growth
defects in vitro indicate that RNI and ROI both contribute,
possibly in a synergistic fashion, to controlling C. burnetii in-
fections. Synergy between RNI and ROI can occur through
various interactions. For example, the interaction of NO with
O2
 results in the formation of toxic peroxynitrite (ONOO),
which has the ability to directly oxidize DNA bases and sulf-
hydryl groups and to cause lipid peroxidation (41). Nitric oxide
has also been demonstrated to inactivate Fe-S-containing en-
zymes such as aconitase, resulting in the release of Fe2, which
can then interact with H2O2 as part of the Haber-Weiss reac-
tion to form toxic hydroxyl radicals that are also capable of
oxidizing proteins, DNA, and lipids (28, 41). The synergistic
effects of RNI and ROI on the inhibition of pathogens have
been previously demonstrated. Pacelli et al. reported that hy-
drogen peroxide-dependent killing of E. coli increased 1,000-
fold in the presence of nitric oxide and could be prevented by
the chelation of iron (45). Another study, by Darrah et al.,
demonstrated that mice lacking iNOS or gp91phox were more
susceptible to lethal challenges of Rhodococcus equi than wild-
type mice and also demonstrated in vitro that efficient killing of
R. equi cells was observed in the presence of peroxynitrite but
not in the presence of nitric oxide or superoxide alone (19).
The passage of protonated superoxide into the C. burnetii-
containing vacuole could potentiate the formation of ONOO.
It was previously demonstrated that NO contributed to the
inhibition of C. burnetii replication in cytokine-stimulated L929
cells by preventing the formation of large replicative vacuoles
(32). Further investigation is required to determine if ROI are
also involved in this mechanism. Finally, the finding that an
iNOS- and NADPH oxidase-independent mechanism(s) may
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also be involved in controlling C. burnetii infections illustrates
the probable complexity and possible redundancy of the innate
immune response to bacterial infections.
The dissemination and lack of clearance of C. burnetii in the
heart valves of iNOS/ and p47phox/ mice suggest that RNI
and ROI may play critical roles in the prevention of C. burnetii-
associated endocarditis, which is the major clinical presenta-
tion of chronic Q fever. The development of chronic Q fever
has often been associated with immunodeficiency (15, 48, 50)
and has only been demonstrated in lab animals that were either
immunosuppressed or had previously damaged heart valves.
Atzpodien et al. reported the dissemination of C. burnetii by 10
days postinfection in cardiac valves of mice treated with cyclo-
phosphamide, and more recently, Andoh et al. demonstrated
that SCID mice infected with C. burnetii developed endocar-
ditis resembling the pathology seen in human Q fever endo-
carditis (6, 8). Those studies involved widespread and nonspe-
cific immunosuppression affecting several potential immune
system mechanisms at various levels. In this study, we have
demonstrated that the specific lack of a functional iNOS or
NADPH oxidase contributes to the colonization and persis-
tence of C. burnetii in cardiac valves. It is possible that the C.
burnetii-associated endocarditis documented in previous stud-
ies may have been in part due to the lack of adequately acti-
vated macrophages and to a poor stimulation of iNOS and
NADPH oxidase. Further characterization of these and other
mouse strains is required to adequately evaluate their useful-
ness as models of Q fever endocarditis.
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